Interesting graph. The U.S. spends a lot more on health R&D, compared to other rich nations, but much less on other kinds of non-military R&D (as a fraction of GDP). Is this more because the U.S. market for drug companies and medical device manufacturers in much more profitable, or more because the NIH has been appropriated lots and lots of money (compared to the NSF, not to TARP!)?